These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34143948)

  • 1. Comparison of Wash-out Properties after Use of the Vital Dye Trypan Blue in the Form of an Ophthalmic Dye and Bound in a Sodium Hyaluronate by Raman Spectroscopy.
    Borkenstein AF; Borkenstein EM; Rattenberger J; Fitzek H; Langenbucher A
    Curr Eye Res; 2021 Nov; 46(11):1653-1658. PubMed ID: 34143948
    [No Abstract]   [Full Text] [Related]  

  • 2. Protocol for vital dye staining of corneal endothelial cells.
    Park S; Fong AG; Cho H; Zhang C; Gritz DC; Mian G; Herzlich AA; Gore P; Morganti A; Chuck RS
    Cornea; 2012 Dec; 31(12):1476-9. PubMed ID: 22531436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypan-blue-stained viscoelastic material for ophthalmic surgery.
    van Nouhuijs HM; van der Berg W; Melles GR
    J Cataract Refract Surg; 2002 Sep; 28(9):1713. PubMed ID: 12231340
    [No Abstract]   [Full Text] [Related]  

  • 4. Quirks of dye nomenclature. 3. Trypan blue.
    Cooksey CJ
    Biotech Histochem; 2014 Nov; 89(8):564-7. PubMed ID: 24867494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypan blue mixed with sodium hyaluronate for capsulorhexis.
    Kayikiçioğlu O; Erakgün T; Güler C
    J Cataract Refract Surg; 2001 Jul; 27(7):970. PubMed ID: 11496911
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of trypan blue for penetrating keratoplasty.
    Roos JC; Kerr Muir MG
    J Cataract Refract Surg; 2005 Oct; 31(10):1867-9. PubMed ID: 16338552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of proliferative diabetic retinopathy using viscosurgery with vital dye.
    Nadal J; Capella MJ
    Arch Ophthalmol; 2011 Oct; 129(10):1358-60. PubMed ID: 21987679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intraoperative complications in intumescent cataract surgery using 2 ophthalmic viscosurgical devices and trypan blue staining.
    Hengerer FH; Dick HB; Kohnen T; Conrad-Hengerer I
    J Cataract Refract Surg; 2015 Apr; 41(4):714-8. PubMed ID: 25840295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical blues: vitreous staining with trypan blue during cataract surgery.
    Wang BZ; Forward H; Farber L; Chiu D; Chandra A
    Clin Exp Ophthalmol; 2014 Nov; 42(8):788-9. PubMed ID: 24617295
    [No Abstract]   [Full Text] [Related]  

  • 10. Three-step technique for staining the anterior lens capsule with indocyanine green or trypan blue.
    Marques DM; Marques FF; Osher RH
    J Cataract Refract Surg; 2004 Jan; 30(1):13-6. PubMed ID: 14967263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic viscosurgical device choice in intumescent cataract.
    Carifi G; Zygoura V; Kopsachilis N
    J Cataract Refract Surg; 2015 Jul; 41(7):1547. PubMed ID: 26287904
    [No Abstract]   [Full Text] [Related]  

  • 12. Ophthalmic viscosurgical devices for intumescent cataracts: pressure-equalized cataract surgery.
    Arshinoff SA
    J Cataract Refract Surg; 2015 Jul; 41(7):1549-50. PubMed ID: 26287907
    [No Abstract]   [Full Text] [Related]  

  • 13. Determining the lowest trypan blue concentration that satisfactorily stains the anterior capsule.
    Yetik H; Devranoglu K; Ozkan S
    J Cataract Refract Surg; 2002 Jun; 28(6):988-91. PubMed ID: 12036641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method to improve dye application to the retinal surface during vitrectomy.
    Schmid MK
    Retina; 2011 Apr; 31(4):801-3. PubMed ID: 21386756
    [No Abstract]   [Full Text] [Related]  

  • 15. Trypan blue with a viscoelastic agent.
    Dada VK; Sudan R; Sharma N; Dada T
    J Cataract Refract Surg; 2002 Feb; 28(2):205-6. PubMed ID: 11821180
    [No Abstract]   [Full Text] [Related]  

  • 16. Crystalline lens capsule staining with trypan blue.
    Laureano JS; Coroneo MT
    J Cataract Refract Surg; 2004 Oct; 30(10):2046-9. PubMed ID: 15474812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of viscous solutions in phacoemulsification and traumatic lens implantation.
    Glasser DB; Katz HR; Boyd JE; Langdon JD; Shobe SL; Peiffer RL
    Arch Ophthalmol; 1989 Jul; 107(7):1047-51. PubMed ID: 2751459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscoanesthesia. Part I: toxicity to corneal endothelial cells in a rabbit model.
    Trivedi RH; Werner L; Apple DJ; Izak AM; Pandey SK; Macky TA
    J Cataract Refract Surg; 2003 Mar; 29(3):550-5. PubMed ID: 12663023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why mix trypan blue with viscoelastic agents?
    Lanzl IM; Mertz MM
    J Cataract Refract Surg; 2003 Feb; 29(2):237. PubMed ID: 12648622
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypan Blue Exclusion Test of Cell Viability.
    Strober W
    Curr Protoc Immunol; 2015 Nov; 111():A3.B.1-A3.B.3. PubMed ID: 26529666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.